Evidence map›Paper›PMID 37852853›Full record

ReviewTrends in biotechnology2024

Emerging granular hydrogel bioinks to improve biological function in bioprinted constructs.

Cody Tuftee, Eben Alsberg, Ibrahim Tarik Ozbolat, Muhammad Rizwan

Open access · greenAbstract readReview
In one paragraph

Review in Trends in biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Cody TufteeDepartment of Biomedical Engineering, Michigan Technological University, Houghton, MI, USA.
Eben AlsbergJesse Brown Veterans Affairs Medical Center (JBVAMC), Chicago, IL 60612, USA; Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL 60612, USA; Department of Orthopedic Surgery, University of Illinois at Chicago, Chicago, IL 60612, USA; Department of Pharmacology and Regenerative Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA; Department of Mechanical & Industrial Engineering, University of Illinois at Chicago, Chicago, IL 60612, USA; Jesse Brown Veterans Affairs Medical Center (JBVAMC) at Chicago, Chicago, IL 60612, USA.
Ibrahim Tarik OzbolatBiomedical Engineering Department, Penn State University, University Park, PA 16802, USA; Engineering Science and Mechanics, Penn State University, University Park, PA 16802, USA; Neurosurgery Department, Penn State University; Hershey, PA 17033, USA; Medical Oncology Department, Cukurova University, Adana 01330, Turkey.
Muhammad RizwanDepartment of Biomedical Engineering, Michigan Technological University, Houghton, MI, USA. Electronic address: mrizwan1@mtu.edu.
Michigan Technological University · USHershey (United States) · USUniversity of Illinois Chicago · US

Funding

Technology Development Project - Increasing the complexity of ex vivo human airway models for studying immune response to viral infectionU19AI142733 · NIAID · JACKSON LABORATORY · PI Anna Karolina Palucka · 2019 to 2026
$23.1M
Intraoperative bioprinting of composite tissues with zonal stratification for craniomaxillofacial reconstructionR01DE028614 · NIDCR · PENNSYLVANIA STATE UNIVERSITY, THE · PI OZBOLAT, IBRAHIM · 2020 to 2024
$2.8M
Individual cell bioprinting to generate multi-tissue type condensations for osteochondral tissue regenerationR01AR081448 · NIAMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Eben Alsberg, Oju Jeon · 2023 to 2026
$1.6M
Bioengineered corneal endothelial graft using photodegradable device to induce graft-host integrationR01EY035305 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI Muhammad Rizwan · 2023 to 2026
$1.5M
Development of Complex Liver Organoids Using Cell-Specific Patterned BiomaterialsR15DK136103 · NIDDK · MICHIGAN TECHNOLOGICAL UNIVERSITY · PI RIZWAN, MUHAMMAD · 2023 to 2023
$443k
NEI NIH HHS R01 EY035305NIAID NIH HHS U19 AI142733NIAMS NIH HHS R01 AR081448NIDCR NIH HHS R01 DE028614NIDDK NIH HHS R15 DK136103RRD VA I01 RX004288
6 · The paper itself

Abstract

Advancements in 3D bioprinting have been hindered by the trade-off between printability and biological functionality. Existing bioinks struggle to meet both requirements simultaneously. However, new types of bioinks composed of densely packed microgels promise to address this challenge. These bioinks possess intrinsic porosity, allowing for cell growth, oxygen and nutrient transport, and better immunomodulatory properties, leading to superior biological functions. In this review, we highlight key trends in the development of these granular bioinks. Using examples, we demonstrate how granular bioinks overcome the trade-off between printability and cell function. Granular bioinks show promise in 3D bioprinting, yet understanding their unique structure-property-function relationships is crucial to fully leverage the transformative capabilities of these new types of bioinks in bioprinting.

Indexed as

BioprintingHydrogelsPrinting, Three-DimensionalTissue EngineeringTissue ScaffoldsHydrogelsbioinksbioprintingextrusiongranular hydrogelsmicrogels

Identifiers

PMID37852853
PMCPMC10939978
OpenAlexW4387666293

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.